Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma
Fulltext:
201751.pdf
Embargo:
until further notice
Size:
493.7Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2019Source
European Journal of Cancer, 110, (2019), pp. 62-70ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Medical Oncology
Pathology
Health Evidence
Urology
Journal title
European Journal of Cancer
Volume
vol. 110
Page start
p. 62
Page end
p. 70
Subject
Radboudumc 15: Urological cancers RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences; Health Evidence - Radboud University Medical Center; Medical Oncology - Radboud University Medical Center; Pathology - Radboud University Medical Center; Radboud University Medical Center; Urology - Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [248471]
- Electronic publications [135728]
- Faculty of Medical Sciences [94202]
Upload full text
Use your RU or RadboudUMC credentials to log in with SURFconext to upload a file for processing by the repository team.